Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis

Open Access

Peer-reviewed

Research Article

Johannes Pfeil,

Affiliations Centre for Childhood and Adolescent Medicine and Department of Infectious Diseases, University Hospital, Heidelberg, Germany, German Centre for Infection Research (DZIF), Heidelberg, Germany
⨯
Steffen Borrmann,

Affiliations Kenyan Medical Research Institute (KEMRI), Kilifi, Kenya, Institute of Tropical Medicine, University of Tübingen, Tübingen, Germany
⨯
Yeşim Tozan

* E-mail: tozan@nyu.edu

Affiliations Steinhardt School of Culture, Education and Human Development, New York University, New York, New York, United States of America, Institute of Public Health, Ruprecht-Karls-University, Heidelberg, Germany
⨯

Reader Comments (0)

Malaria
Is the Subject Area "Malaria" applicable to this article?

Thanks for your feedback.
Antimalarials
Is the Subject Area "Antimalarials" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Prophylaxis
Is the Subject Area "Prophylaxis" applicable to this article?

Thanks for your feedback.
Drug prices
Is the Subject Area "Drug prices" applicable to this article?

Thanks for your feedback.
Markov models
Is the Subject Area "Markov models" applicable to this article?

Thanks for your feedback.
Plasmodium
Is the Subject Area "Plasmodium" applicable to this article?

Thanks for your feedback.
Hospitals
Is the Subject Area "Hospitals" applicable to this article?

Thanks for your feedback.